Stramsen Biotech, Inc. — Regulation A 1-A

Stramsen Biotech, Inc. of Houston, TX filed a Regulation A 1-A with the SEC on 2024-11-06. Aggregate offering: $20.0M (Tier 1). Industry: Other.

Offering

• Filed: 2024-11-06
• Form: 1-A
• Accession: 0001099910-24-000364
• Tier: Tier 1
• Total aggregate offering: $20.0M
• Issuer portion: $20.0M
• Price per security: $1.2000
• Securities offered: Equity (common or preferred stock)
• Audit status: Unaudited
• Jurisdictions: 52 states/territories

Issuer

• CIK: 0001943948
• Organized in: DE
• Incorporated: 2020
• Address: 5718 Westheimer Rd, Houston, TX, 77057
• Phone: 713-955-1156
• Employees: 20 full-time

Financial snapshot (as filed)

• Total assets: $23K
• Cash & equivalents: $350
• Total liabilities: $57K
• Stockholder equity: $-34K
• Net income: $-110K

People (1)

More

• CIK 1943948 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search